音量 10, 問題 2 (2020)
総説
Clinical impact potential of Rejuveinix (RJX) for prevention of fatal acute respiratory distress syndrome (ARDS) and multi-organ failure in COVID-19 patients.
Fatih M. Uckun*, Jim Ervin, Kazim Sahin, Joy Powell, Natalie Pizzimenti, Jackie Earabino, Hendrik van Wyk, Mariette van Wyk, Peter Pacult, Taha Koray Sahin, Kristina Cabala
総説
Selectively targeting TGF-β with Trabedersen/OT-101 in treatment of evolving and mild ards in COVID-19
Fatih M. Uckun, Larn Hwang, Vuong Trieu
研究論文
A phase 1 study on midostaurin plus panobinostat in unfit acute myeloid leukemia and high-risk myelodysplastic syndrome
Chin-Hin NG*, Weiying JEN, Liang-Piu KOH, Melissa OOI, Esther CHAN, Maria-Jannet MOGRO, Shi WANG, Jianbiao ZHOU, Wee-Joo CHNG
